Acta Scientific ANATOMY

Review Article Volume 2 Issue 5

Hepatocellular Cancer, the Killer Disease, It’s Etiology, Pathological Orientation, Genomic Pathway, A Concern to the 21st Century’s Field of Medicine BY E.E. GODSWILL (B.SC, ASN,)

Emmanson Emmanson Godswill*

Department of Human Anatomy, Cross River University of Technology, Nigeria

*Corresponding Author: Emmanson Emmanson Godswill, Department of Human Anatomy, Cross River University of Technology, Nigeria.

Received: August 24, 2023; Published: September 23, 2023

Abstract

Hepatocellular carcinoma (HCC) is a malignant tumor of the liver that poses a significant global health burden in the 21st century. It is characterized by high mortality rates and increasing incidence worldwide, reflecting the challenges and opportunities for the medical field. This introduction reviews the current discoveries of Hepatocellular Carcinoma, to cover the broader aspect of the etiology, pathology, genomics, and implications HCC for the 21st century medicine.

References

  1. Bruix J and Sherman M. “Management of hepatocellular carcinoma: an update”. Hepatology3 (2011): 1020-1022.
  2. El-Serag HB. “Hepatocellular carcinoma”. New England Journal of Medicine12 (2011): 1118-1127.
  3. Forner A., et al. “Hepatocellular carcinoma”. The Lancet10127 (2018): 1301-1314.
  4. Llovet JM and Bruix J. “Molecular targeted therapies in hepatocellular carcinoma”. Hepatology 4 (2008): 1312-1327.
  5. Singal AG., et al. “Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice”. Clinical Gastroenterology and Hepatology2 (2019): 195-206.
  6. Farazi PA and DePinho RA. “Hepatocellular carcinoma pathogenesis: from genes to environment”. Nature Reviews Cancer9 (2006): 674-687.
  7. Nault JC and Zucman-Rossi J. “Genetics of hepatobiliary carcinogenesis”. Seminars in Liver Disease 2 (2019): 169-185.
  8. Villanueva A and Llovet JM. “Targeted therapies for hepatocellular carcinoma”. Gastroenterology 6 (2012): 1340-1355.
  9. Chaffer CL and Weinberg RA. “A perspective on cancer cell metastasis”. Science 6024 (2011): 1559-1564.
  10. Hoshida Y., et al. “Gene expression in fixed tissues and outcome in hepatocellular carcinoma”. New England Journal of Medicine19 (2008): 1995-2004.

Citation

Citation: Emmanson Emmanson Godswill. “Hepatocellular Cancer, the Killer Disease, It’s Etiology, Pathological Orientation, Genomic Pathway, A Concern to the 21st Century’s Field of Medicine BY E.E. GODSWILL (B.SC, ASN,)".Acta Scientific Anatomy 2.6 (2023): 07-08.

Copyright

Copyright: © 2023 Emmanson Emmanson Godswill. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US





//